Speaker illustration

Doctor Karin Jennbacken

Kallered (Sweden)

A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction

Date: 3 March 2025

Journal: Cardiovascular Research

Thumbnail

ESC 365 is supported by